Evanston Advisors’s AbbVie ABBV Stock Holding History

Evanston Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$8.47M	Buy	91,888 +687	+0.8%	+$60.4K	2.3%	12
2018 Q3	$8.63M	Buy	+91,201	New	+$8.65M	1.88%	23
2017 Q3	–	Sell	-2,982	Closed	-$216K	–	67
2017 Q2	$216K	Buy	+2,982	New	+$200K	0.05%	61
2014 Q2	–	Sell	-103,147	Closed	-$5.3M	–	62
2014 Q1	$5.3M	Buy	103,147 +3,075	+3%	+$155K	1.9%	21
2013 Q4	$5.29M	Buy	+100,072	New	+$4.92M	1.99%	23

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Evanston Advisors's ABBV Position: Q4 2018 in Review

Evanston Advisors increased its AbbVie (ABBV) stake by 0.75% in Q4 2018, buying an estimated $60.4K and bringing the position to 91,888 shares worth $8.47M. The position accounts for 2.3% of the portfolio, ranked #12.

Evanston Advisors first reported a position in ABBV in Q4 2013 and has held it in 5 quarters since. The position peaked at $8.63M in Q3 2018. 2,062 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Evanston Advisors held 91,888 shares of AbbVie worth $8.47M as of Q4 2018.
Evanston Advisors bought 687 AbbVie shares in Q4 2018, an estimated $60.4K.
AbbVie made up 2.3% of Evanston Advisors's portfolio in Q4 2018, its #12 holding.
Evanston Advisors first reported a position in AbbVie in Q4 2013 and has held it in 5 quarters since.
Evanston Advisors's AbbVie position peaked at $8.63M in Q3 2018.
2,062 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Evanston Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.